These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 1790160

  • 1. Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder?
    Maier W, Roth SM, Argyle N, Buller R, Lavori P, Brandon S, Benkert O.
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(3):151-8. PubMed ID: 1790160
    [Abstract] [Full Text] [Related]

  • 2. The structure of phobias in panic disorder.
    Argyle N, Solyom C, Solyom L.
    Br J Psychiatry; 1991 Sep; 159():378-82. PubMed ID: 1958949
    [Abstract] [Full Text] [Related]

  • 3. Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment.
    Maier W, Rosenberg R, Argyle N, Buller R, Roth M, Brandon S, Benkert O.
    Eur Arch Psychiatry Clin Neurosci; 1991 Sep; 241(1):22-30. PubMed ID: 1832302
    [Abstract] [Full Text] [Related]

  • 4. Sequence of improvement in agoraphobia with panic attacks.
    Rifkin A, Pecknold JC, Swinson RP, Ballenger JC, Burrows GD, Noyes R, Dupont RL, Lesser I.
    J Psychiatr Res; 1990 Sep; 24(1):1-8. PubMed ID: 2195163
    [Abstract] [Full Text] [Related]

  • 5. Drug treatment of panic disorder: early response to treatment as a predictor of final outcome.
    Albus M, Lecrubier Y, Maier W, Buller R, Rosenberg R, Hippius H.
    Acta Psychiatr Scand; 1990 Nov; 82(5):359-65. PubMed ID: 2281806
    [Abstract] [Full Text] [Related]

  • 6. A controlled study of alprazolam and propranolol in panic-disordered and agoraphobic outpatients.
    Ravaris CL, Friedman MJ, Hauri PJ, McHugo GJ.
    J Clin Psychopharmacol; 1991 Dec; 11(6):344-50. PubMed ID: 1770152
    [Abstract] [Full Text] [Related]

  • 7. Treatment of panic disorder.
    Cassano GB, Toni C, Musetti L.
    Adv Biochem Psychopharmacol; 1992 Dec; 47():449-60. PubMed ID: 1509926
    [No Abstract] [Full Text] [Related]

  • 8. Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam.
    Swinson RP, Pecknold JC, Kuch K.
    Prog Neuropsychopharmacol Biol Psychiatry; 1987 Dec; 11(2-3):105-13. PubMed ID: 3628823
    [Abstract] [Full Text] [Related]

  • 9. A meta-analysis of treatments for panic disorder with agoraphobia: imipramine, alprazolam, and in vivo exposure.
    Cox BJ, Endler NS, Lee PS, Swinson RP.
    J Behav Ther Exp Psychiatry; 1992 Sep; 23(3):175-82. PubMed ID: 1487535
    [Abstract] [Full Text] [Related]

  • 10. Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks.
    Munjack DJ, Crocker B, Cabe D, Brown R, Usigli R, Zulueta A, McManus M, McDowell D, Palmer R, Leonard M.
    J Clin Psychopharmacol; 1989 Feb; 9(1):22-7. PubMed ID: 2651490
    [Abstract] [Full Text] [Related]

  • 11. Relationship of panic, anticipatory anxiety, agoraphobia and global improvement in panic disorder with agoraphobia treated with alprazolam and exposure.
    Başoğlu M, Marks IM, Kiliç C, Swinson RP, Noshirvani H, Kuch K, O'Sullivan G.
    Br J Psychiatry; 1994 May; 164(5):647-52. PubMed ID: 7921715
    [Abstract] [Full Text] [Related]

  • 12. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo.
    Keller MB, Lavori PW, Goldenberg IM, Baker LA, Pollack MH, Sachs GS, Rosenbaum JF, Deltito JA, Leon A, Shear K.
    J Affect Disord; 1993 May; 28(1):27-38. PubMed ID: 8326078
    [Abstract] [Full Text] [Related]

  • 13. Chronology of panic and avoidance, age of onset in panic disorder, and prediction of treatment response. A report from the Cross-National Collaborative Panic Study.
    Buller R, Maier W, Goldenberg IM, Lavori PW, Benkert O.
    Eur Arch Psychiatry Clin Neurosci; 1991 May; 240(3):163-8. PubMed ID: 1827602
    [Abstract] [Full Text] [Related]

  • 14. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.
    Taylor CB, Hayward C, King R, Ehlers A, Margraf J, Maddock R, Clark D, Roth WT, Agras WS.
    J Clin Psychopharmacol; 1990 Apr; 10(2):112-8. PubMed ID: 2187912
    [Abstract] [Full Text] [Related]

  • 15. Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients.
    Pols H, Verburg K, Hauzer R, Meijer J, Griez E.
    Biol Psychiatry; 1996 Nov 01; 40(9):913-7. PubMed ID: 8896779
    [Abstract] [Full Text] [Related]

  • 16. Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
    Schweizer E, Rickels K, Weiss S, Zavodnick S.
    Arch Gen Psychiatry; 1993 Jan 01; 50(1):51-60. PubMed ID: 8422222
    [Abstract] [Full Text] [Related]

  • 17. A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder.
    Lydiard RB, Lesser IM, Ballenger JC, Rubin RT, Laraia M, DuPont R.
    J Clin Psychopharmacol; 1992 Apr 01; 12(2):96-103. PubMed ID: 1573046
    [Abstract] [Full Text] [Related]

  • 18. Maintenance drug therapy of panic disorder.
    Curtis GC, Massana J, Udina C, Ayuso JL, Cassano GB, Perugi G.
    J Psychiatr Res; 1993 Apr 01; 27 Suppl 1():127-42. PubMed ID: 8145175
    [Abstract] [Full Text] [Related]

  • 19. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
    Charney DS, Woods SW, Goodman WK, Rifkin B, Kinch M, Aiken B, Quadrino LM, Heninger GR.
    J Clin Psychiatry; 1986 Dec 01; 47(12):580-6. PubMed ID: 3536889
    [Abstract] [Full Text] [Related]

  • 20. Three cases of panic disorder with agoraphobia in children.
    Ballenger JC, Carek DJ, Steele JJ, Cornish-McTighe D.
    Am J Psychiatry; 1989 Jul 01; 146(7):922-4. PubMed ID: 2742019
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.